Award
National Institute of Allergy and Infectious Diseases 1SB1AI192001-01A1
Bloodstream infection detection directly on whole blood
Recipient
Scanogen, Inc.
Award Amount
$969,449.00
Ceiling
$969,449.00
Awarded
September 15, 2025
Identifier
1SB1AI192001-01A1
Award for developing rapid detection technology for bloodstream infections from whole blood, including manufacturing and software development, funded by NIAID.
Description
The project aims to develop manufacturing processes for reagents, cartridges, and instruments in compliance with FDA regulations. It includes software development with cybersecurity and LIS communication capabilities. The project focuses on rapid detection of bloodstream infections directly from whole blood, targeting yeast pathogens including Candida species. The project duration is from September 17, 2025, to August 31, 2028.